about
Bluetongue Virus NS4 Protein Is an Interferon Antagonist and a Determinant of Virus VirulenceBluetongue virus: dissection of the polymerase complexNovel virostatic agents against bluetongue virusTrafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner.A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.Structural constraints in the packaging of bluetongue virus genomic segments.Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.Susceptibility of in vitro produced hatched bovine blastocysts to infection with bluetongue virus serotype 8.In vitro reconstitution of Bluetongue virus infectious cores.Characterising Non-Structural Protein NS4 of African Horse Sickness VirusMultiple genome segments determine virulence of bluetongue virus serotype 8Influence of cellular trafficking pathway on bluetongue virus infection in ovine cellsDevelopment of an insect vector cell culture and RNA interference system to investigate the functional role of fijivirus replication protein.The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway.Structural insight into African horsesickness virus infection.Comparative analysis of Reoviridae reverse genetics methods.Cell Walls and the Convergent Evolution of the Viral Envelope.Endocytic uptake pathways utilized by CPMV nanoparticles.Cellular phosphoinositides and the maturation of bluetongue virus, a non-enveloped capsid virus.Entry of Bluetongue Virus Capsid Requires the Late Endosome-specific Lipid Lysobisphosphatidic Acid.Prospects for improved bluetongue vaccines.Bluetongue vaccines: the past, present and future.Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.Role of lipids on entry and exit of bluetongue virus, a complex non-enveloped virusBluetongue virus capsid assembly and maturation.The requirement of environmental acidification for Ibaraki virus infection to host cells.Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain.Membrane permeabilization of the African horse sickness virus VP5 protein is mediated by two N-terminal amphipathic α-helices.Viruses That Exploit Actin-Based Motility for Their Replication and Spread.Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.Analysis of Conserved, Computationally Predicted Epitope Regions for VP5 and VP7 Across three Orbiviruses.1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features.In Silico Studies on Development of Novel Virostatic Agents against Bluetongue Virus
P2860
Q26700161-379405DE-79F0-4A07-85D5-B1567CF68637Q27489424-368E4B9B-63B5-4C4F-BA00-C7DAD90BCDFEQ28482273-BAFDA5EC-3503-46CB-BF68-330423C296BAQ30603531-9DC0D59C-83E6-46B1-BA9D-393E9D85BE49Q30603656-738C3BE6-D02F-495B-898F-5CA24196A887Q33627567-9026B86A-E35C-4DF1-8BBA-9244F5C2A267Q34196457-E024CB94-595E-4A13-900A-C22C554B6CA8Q34204054-78370863-FA29-4220-91BF-D40A8DDBC8F2Q34569587-7DAD20C8-D773-400A-960C-81F08AADC4A5Q35170961-A59F5AEF-2C15-4778-9053-573AB27EB0FDQ35542582-0BDB61B3-0C52-4247-ACD1-390011175BECQ35641548-C465F472-356D-4CCD-A229-5EB9989CF176Q35676008-A6717E08-BA90-4F4E-B35E-01B547426E52Q35943431-878B6888-37EA-4303-A500-C19D3E550C82Q35943563-7585BB5C-3EAA-4C37-A0EB-EB4CC08BAB7CQ36171865-B075F977-0C7A-4A24-8034-D1A7624E5D56Q36253330-91E30ED7-2A6A-4149-B6BF-8F76540D6403Q36294722-E27D5716-5823-4A35-AD8D-1F0EE71D65ABQ36662073-9A5E83BC-B860-4E75-A094-C8503E971C4EQ36690080-E36C5220-7ADB-42A6-BF01-F9015FDA3EA9Q37066080-E9A42667-8EA4-4CD6-94B2-0FBA3B8D2E8FQ37369882-38776951-A6EE-449C-9239-2D70EA6FFF83Q37386291-340804A3-A03D-4752-8049-A8C3ADE71DD2Q37512822-4FEF7BB0-7530-4B7C-A412-EB10AA802A48Q37945206-6E3C789B-7269-4F10-A200-2F06582EA274Q38246708-B18E73D2-E897-4F9F-812E-45227D5C78D9Q38373418-0831C721-93F5-4EC9-872A-DDB2DEFCEFABQ38907880-CA49F124-4EA4-40E4-A878-B0ADE0886B7AQ39613790-48315493-4215-452F-82CC-C2AE32A5EE07Q40531470-C8B84C98-C169-46D6-A9C4-5337805E1805Q45353031-A505F02D-2C27-4981-8CA6-6F86BAD6E045Q50054811-20CFAE08-B941-41F8-8A24-749CE8C30B3AQ54976877-7E3460C2-62E2-4BB4-8F02-C9A402C6FA94Q59048200-1AD406A0-0535-4EC8-8B29-452DA84AE766
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bluetongue virus entry into cells
@en
Bluetongue virus entry into cells.
@nl
type
label
Bluetongue virus entry into cells
@en
Bluetongue virus entry into cells.
@nl
prefLabel
Bluetongue virus entry into cells
@en
Bluetongue virus entry into cells.
@nl
P2860
P50
P356
P1433
P1476
Bluetongue virus entry into cells
@en
P2093
P2860
P304
P356
10.1128/JVI.02284-06
P407
P577
2007-01-31T00:00:00Z